CHAIN Biotechnology is a live biotherapeutics company founded in 2014 and based in Nottingham and Marlow, UK. CHAIN works with the Synthetic Biology Research Centre in Nottingham and has built a live biotherapeutic platform based on Clostridia being to deliver bioactive molecules to treat diseases associated with the human gut microbiome.
On September 12, 2017 CHAIN Biotechnology received a grant worth £500,000 from Innovative UK.
Biotech Focus: Interview with Dr Edward Green, CHAIN Biotechnology - Microbiome Times Magazine
IChemE Awards 2016 Finalist - 'Clostridium for high-value chemical production', CHAIN Biotechnology
October 10, 2016
No more activity to show.